Petri Bono

Turku, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications

Health-system burden of higher-risk myelodysplastic syndromes in England: a literature-based micro-cost analysis.

Health-system burden of higher-risk myelodysplastic syndromes in England: a literature-based micro-cost analysis.

Journal: BMJ open
Published: August 28, 2026

Beyond the Catalogue: Design and Biological Enrichment as the Next Priorities in Higher-Risk MDS Drug Development.

Beyond the Catalogue: Design and Biological Enrichment as the Next Priorities in Higher-Risk MDS Drug Development.

Journal: European journal of haematology
Published: June 07, 2026

Learning from late-stage trial failures in higher-risk myelodysplastic syndromes: towards adaptive and biomarker-enriched designs.

Learning from late-stage trial failures in higher-risk myelodysplastic syndromes: towards adaptive and biomarker-enriched designs.

Journal: Expert review of anticancer therapy
Published: February 28, 2026

The impact of COVID-19 on healthcare booking and cancellation patterns: time series analysis of private healthcare service utilisation in Finland.

The impact of COVID-19 on healthcare booking and cancellation patterns: time series analysis of private healthcare service utilisation in Finland.

Journal: BMC health services research
Published: October 13, 2023

The impact of COVID-19 on private healthcare service utilisation: time series analysis in the capital region of Finland during 2020-2022.

The impact of COVID-19 on private healthcare service utilisation: time series analysis in the capital region of Finland during 2020-2022.

Journal: BMC public health
Published: September 01, 2023

Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer.

Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer.

Journal: Prostate cancer and prostatic diseases
Published: June 08, 2023

Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments.

Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune Microenvironments.

Journal: Cancer immunology research
Published: April 24, 2023

Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.

Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial.

Journal: Cell reports. Medicine
Published: April 19, 2023

Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.

Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.

Journal: The Journal of clinical investigation
Published: August 25, 2022

C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients.

C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients.

Journal: Acta oncologica (Stockholm, Sweden)
Published: July 29, 2022

Time series analysis of the incidence of acute upper respiratory tract infections, COVID-19 and the use of antibiotics in Finland during the COVID-19 epidemic: a cohort study of 833 444 patients.

Time series analysis of the incidence of acute upper respiratory tract infections, COVID-19 and the use of antibiotics in Finland during the COVID-19 epidemic: a cohort study of 833 444 patients.

Journal: BMJ open
Published: February 02, 2022

Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.

Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 12, 2022
Showing 1-12 of 72

Last Updated: 09/26/2026